(Date:11/25/2009)...AND,Colo.,Nov.25/PRNewswire-FirstCall/--HeskaCorpo...ddiagnosticandspecialtyproductstotheveterinaryindu...orporationforthesupplyofbloodgasproductsandaffilia... http://www.newscom.com/cgi-bin/prnh/20000622/HESK...innovatinginthefieldofadvancedpoint-of-carediagnos...
(Date:11/25/2009)...,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,In... report,thefirstinamulti-phasesyndicatedmarketres...ch,sStelara,fromproductlaunchthroughthefirstsixmon...itativeinformationfrom75uniqueDermatologistsandqua...strialanduseofStelara,obstaclestouse,typicalpatien...
(Date:11/25/2009)...NGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences...hromboticaptamerswithactivecontrolagents,announced...gatthePiperJaffray21stAnnualHealthCareConferenceat...ntationwillbegivenat1:10pm(EST)onTuesday,December1...emphasisontheleaddevelopmentprogram,theanticoagula...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 1D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 2D Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering 28IPO 29 on the Tel Aviv Stock Exchange 28TASE 29 4857 3Genetic Discovery May Improve Hepatitis C Treatment 54618 1Genetic Discovery May Improve Hepatitis C Treatment 54618 2...ehensive overview of clinical trials, ...AGO, Aug. 13 Aon eSolutions, the client,technolog...ding provider of,global risk and insurance solutio... Trials module as part of RiskConsole, the market-...system (RMIS)., (Logo: http://www.newscom.com/cg...
... could provide therapeutic benefit in c...ARLSBAD, Calif., Aug. 13 Isis,Pharmaceuticals, In...ed a,Phase 1 study of ISIS 353512, an antisense dr...ein (CRP). CRP levels are frequently elevated,in p...ovascular disease,Crohn,s disease, rheumatoid arth...
Other Medicine Technology:Aon eSolutions Launches Clinical Trials Module 2Aon eSolutions Launches Clinical Trials Module 3Aon eSolutions Launches Clinical Trials Module 4Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3(Date:11/25/2009)...NFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQualit...r Spare the Air Alert forThursday,No...logsoranyothersolidfuel,bothindoorsandoutdoors. ,...qualitytomorrow,"saidJackBroadbent,executiveoffice...spectthehealthoftheirneighborsandfellowcommunityme...
(Date:11/25/2009)...m survivors of testicular cancer who were treated ...side effects, including neurological side effects ...treated with chemotherapy, according to a new stud...the National Cancer Institute . , Marianne Brydy...niversity Hospital, in Bergen, Norway, and colleag...
(Date:11/25/2009)...uitous discovery that grew out of a collaboration ...ially offer hope to the nearly 10 million American... , Also known as hardening of the arteries, peri...latory problem in which narrowed arteries reduce b...d a red flag for vascular disease, heart attack an...
(Date:11/25/2009)...follow-up period was too short to draw definite co...Nov. 25 (HealthDay News) -- In diabetic patients w... no difference in outcomes at one year whether pat...tenting, British researchers report. , Bypass s...c patients with coronary artery disease. However, ...
(Date:11/25/2009)... Evaluation and treatment clinics t... Woodstock (Vocus) November 25, 2009 -- Centegra ...ccines and H1N1 vaccine shots at four Centegra Pri...shipment of vaccine has arrived. The clinics are a...d McHenry and will be open as follows: ,  ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: